Yale University

Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.

TitleScaling up antiretroviral therapy in South Africa: the impact of speed on survival.
Publication TypeJournal Article
Year of Publication2008
AuthorsWalensky, Rochelle P., Robin Wood, Milton C. Weinstein, Neil A. Martinson, Elena Losina, Mariam O. Fofana, Sue J. Goldie, Nomita Divi, Yazdan Yazdanpanah, Bingxia Wang, David A. Paltiel, and Kenneth A. Freedberg
Corporate AuthorsCEPAC-International Investigators
JournalThe Journal of infectious diseases
Volume197
Issue9
Pagination1324-32
Date Published2008 May 1
ISSN0022-1899
KeywordsAcquired Immunodeficiency Syndrome, Adult, Anti-Retroviral Agents, Antiretroviral Therapy, Highly Active, Cohort Studies, HIV Infections, Humans, Models, Biological, South Africa
AbstractOnly 33% of eligible human immunodeficiency virus (HIV)-infected patients in South Africa receive antiretroviral therapy (ART). We sought to estimate the impact of alternative ART scale-up scenarios on patient outcomes from 2007-2012.
DOI10.1086/587184
Alternate JournalJ. Infect. Dis.

External Links